Exosomes regulate doxorubicin resistance in breast cancer via miR-34a-5p/ NOTCH1

被引:3
|
作者
Chen, Nan-nan [1 ]
Zhou, Ke-fan [2 ]
Miao, Zhuang [1 ]
Chen, Yun-xia [2 ]
Cui, Jing-xia [2 ]
Su, Su -wen [1 ]
机构
[1] Hebei Med Univ, Minist Educ, Key Lab Neural & Vasc Biol, Key Lab New Drug Pharmacol & Toxicol,Dept Pharmaco, Shijiazhuang 050017, Hebei, Peoples R China
[2] Hebei Med Univ, Sch Pharm, Key Lab Innovat Drug Res & Safety Evaluat, Shijiazhuang 050017, Hebei, Peoples R China
关键词
Exosome; Breast cancer; miRNA; Doxorubicin; Chemoresistance; SUPPRESSES;
D O I
10.1016/j.mcp.2024.101964
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Breast cancer (BRCA) is the most common cancer among women. Adriamycin (ADR), also known as doxorubicin (Dox), is a commonly used chemotherapeutic agent for BRCA patients, however, the susceptibility of tumor cells to develop resistance to Dox has severely limited its clinical use. One new promising therapeutic target for breast cancer patients is exosomes. The objective of this study was to investigate the role of exosomes in regulating Dox resistance in BRCA. In this study, the exosomes from both types of cells were extracted by differential centrifugation. The effect of exosomes on drug resistance was assessed by laser confocal microscopy, MTT assay, and qRT-PCR. The miRNA was transfected into cells using Lipofectamine 2000, which was then evaluated for downstream genes and changes in drug resistance. Exosomes from MCF-7 cells (MCF-7/exo) and MCF-7/ADR cells (ADR/exo) were effectively extracted in this study. The ADR/exo was able to endocytose MCF-7 cells and make them considerably more resistant to Dox. Moreover, we observed a significant difference in miR-34a-5p expression in MCF-7/ADR and ADR/exo compared to MCF-7 and MCF-7/exo. Among the miR-34a-5p target genes, NOTCH1 displayed a clear change with a negative correlation. In addition, when miR-34a-5p expression was elevated in MCF-7/ADR cells, the expression of miR-34a-5p in ADR/exo was also enhanced alongside NOTCH1, implying that exosomes may carry miRNA into and out of cells and perform their function. In conclusion, exosomes can influence Dox resistance in breast cancer cells by regulating miR-34a-5p/ NOTCH1. These findings provide novel insights for research into the causes of tumor resistance and the enhancement of chemotherapy efficacy in breast cancer.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] MiR-139-5p inhibits migration and invasion of colorectal cancer by downregulating AMFR and NOTCH1
    Song, Mingxu
    Yin, Yuan
    Zhang, Jiwei
    Zhang, Binbin
    Bian, Zehua
    Quan, Chao
    Zhou, Leyuan
    Hu, Yaling
    Wang, Qifeng
    Ni, Shujuan
    Fei, Bojian
    Wang, Weili
    Du, Xiang
    Hua, Dong
    Huang, Zhaohui
    PROTEIN & CELL, 2014, 5 (11) : 851 - 861
  • [32] Ligustrazine prevents coronary microcirculation dysfunction in rats via suppression of miR-34a-5p and promotion of Sirt1
    Gao, Jie
    Ren, Junguo
    Ma, Xin
    Zhang, Ying
    Song, Lei
    Liu, Jianxun
    Shi, Dazhuo
    Ma, Xiaojuan
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2022, 929
  • [33] LINC00665 functions as a competitive endogenous RNA to regulate AGTR1 expression by sponging miR-34a-5p in glioma
    Dai, Yongyue
    Zhang, Yucheng
    Hao, Maolin
    Zhu, Renwu
    ONCOLOGY REPORTS, 2021, 45 (03) : 1202 - 1212
  • [34] Elevated levels of circulating miR-34a-5p and miR-181c-3p during cancer initiation by aflatoxin B1
    Livingstone, Merricka C.
    Roebuck, Bill D.
    Johnson, Natalie M.
    Kensler, Thomas W.
    Groopman, John D.
    CANCER RESEARCH, 2017, 77
  • [35] Colorectal cancer cell-derived exosomes containing miR-183-5p regulate angiogenesis via FOXO1
    Shang, Anquan
    Gu, Chenzheng
    Wu, Junlu
    Ji, Ping
    Sun, Zujun
    Li, Dong
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [36] NEAT1 regulates cell proliferation and apoptosis of ovarian cancer by miR-34a-5p/BCL2
    Ding, Nan
    Wu, Haiying
    Tao, Tao
    Peng, Erxuan
    ONCOTARGETS AND THERAPY, 2017, 10 : 4905 - 4915
  • [37] Original miR-34a-5p enhances the sensitivity of cervical cancer cells to oxaliplatin chemotherapy via targeting MDM4
    He, Pei
    Liu, XiaoLi
    Lou, YanQin
    Gong, ShiXiong
    Cao, LiRong
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2022, 49 (02):
  • [38] MicroRNA-34a suppresses breast cancer cell proliferation and invasion by targeting Notch1
    Rui, Xiaoping
    Zhao, Haibin
    Xiao, Xianqiu
    Wang, Li
    Mo, Lin
    Yao, Yao
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 16 (06) : 4387 - 4392
  • [39] Hsa-miR-34a-5p调控NOTCH1抑制胃癌细胞增殖的机制研究
    周琼
    张斌成
    智慧健康, 2021, 7 (31) : 186 - 193
  • [40] Tanshinone IIA improves diabetes-induced renal fibrosis by regulating the miR-34-5p/Notch1 axis
    Zhang, Lizhi
    Yang, Fan
    FOOD SCIENCE & NUTRITION, 2022, 10 (11): : 4019 - 4040